Den Helder, Netherlands

Mark David Hermeler

This inventor holds 1 USPTO granted patent. Top assignee: Curium US LLC. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark David Hermeler. Retrieved from https://idiyas.com/inventor/mark-david-hermeler

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mark David Hermeler: Innovator in Molybdenum-99 Purification

Introduction

Mark David Hermeler is a notable inventor based in Den Helder, Netherlands. He has made significant contributions to the field of isotope purification, particularly focusing on molybdenum-99, which is crucial for medical applications.

Latest Patents

Hermeler holds a patent for "Methods for purifying molybdenum-99." This patent discloses innovative techniques for extracting the molybdenum-99 isotope. The process involves loading molybdenum-99 onto an anion exchange column and utilizing an extraction solution that may include nitric acid and nitrate salts. In certain embodiments, a two-stage elution is performed, employing a nitric acid-containing eluent followed by a hydroxide-containing eluent to effectively extract molybdenum-99.

Career Highlights

Hermeler is currently associated with Curium US LLC, where he applies his expertise in isotope purification. His work is pivotal in enhancing the efficiency and effectiveness of medical isotopes used in diagnostic imaging and treatment.

Collaborations

He collaborates with esteemed colleagues, including Luis Antonio M M Barbosa and Frits Dekker, contributing to advancements in their field through shared knowledge and expertise.

Conclusion

Mark David Hermeler's innovative work in the purification of molybdenum-99 showcases his commitment to advancing medical technology. His contributions are vital for improving healthcare outcomes through enhanced diagnostic capabilities.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…